СтартапыIsomorphic Labs raises $2.1 billion: a signal for AI...
Isomorphic Labs, founded by DeepMind co-founder Demis Hassabis, closed a financing round of $2.1 billion with participation from Thrive Capital, Alphabet, GV, Temasek, CapitalG, and the UK Sovereign AI Fund. This is one of the largest rounds in the history of AI biotech, with the company not disclosing details of its product pipeline and clinical trial timelines. Investors are betting on a computational approach to drug design and a scalable platform rather than a classic story about a specific molecule. For startups from Kazakhstan and Central Asia, this is a signal: the market is ready to finance deep AI platforms if the technological level is comparable to that of leaders, and companies like Alashed IT (it.alashed.kz) can become technology partners for such projects.